speb/financial-data huggingface dataset:
Financial ratios for IFBD — annual report dated 2024-12-31
Total revenue: 196965.4794520548
Gross profit: 81179.72602739726
Operating income: -237630.68493150687
Net income: -287539.31506849313
Capital expenditures: 105315.4794520548
Operating cash flow: 445464.1095890411
Depreciation & amortization: 15480.82191780822
Net tangible assets: 320121.09589041094
Owner earnings: -377373.9726027397
Return on net tangible assets (%): -117.88475593996108
Buffett classification: The Gruesome
Stock price: 2.26
Shares outstanding: 8188574
Book value: 9150920.136986302
P/B ratio: 2.0223296633528145
Market cap (USD): 18506177.24
Debt to equity: 0.007563054105330855
Current ratio: 2.6335745306536813
Quick ratio: 2.6335745306536813
Interest coverage ratio: -3.174061570833905
COGS to revenue (%): 58.78479505483194
R&D to revenue (%): 1.0483722896996066
SG&A to revenue (%): 160.812686737402
Free cash flow (dilution-adjusted): 340148.6301369863
Buyback yield (%): 0
Retained earnings: -3658010.684931507
Receivables turnover: 0.27738250557669153
Capitalized R&D asset: 2064.931506849315
ROCI (R&D-adjusted, %): -2.464533888784262
FCF margin (%): 172.69454073031363
Revenue growth (%): 400.15162818003915
Rule of 40 score: 572.8461689103528
Financial ratios for IFBD — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 593002.510460251
Buffett classification: The Gruesome
Stock price: 1.13
Shares outstanding: 8188574
Book value: 9583046.443514645
P/B ratio: 0.9655685876657787
Market cap (USD): 9253088.62
Debt to equity: 0.007062871068958178
Current ratio: 2.5467053429530986
Quick ratio: 2.5467053429530986
Buyback yield (%): 0
Retained earnings: -3947097.768479777
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INDP — annual report dated 2021-12-31
Capital expenditures: 3854
Buffett classification: The Gruesome
Stock price: 159.6
Shares outstanding: 133242324
Market cap (USD): 21265474910.399998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INDP — annual report dated 2022-12-31
Total revenue: 0
Operating income: -14910906
Net income: -14322798
Capital expenditures: 0
Operating cash flow: -13078347
Depreciation & amortization: 1781
Net tangible assets: 24630465
Owner earnings: -14321017
Return on net tangible assets (%): -58.14351048589622
Buffett classification: The Gruesome
Stock price: 40.6
Shares outstanding: 133242324
Book value: 24630465
P/B ratio: 219.63200266012032
Market cap (USD): 5409638354.400001
Debt to equity: 0.0032680665996358575
Current ratio: 7.935198397129793
Quick ratio: 7.935198397129793
Free cash flow (dilution-adjusted): -16035596
Buyback yield (%): 0
Retained earnings: -29993685
Capitalized R&D asset: 6324657
ROCI (R&D-adjusted, %): -34.548298662819036
Rule of 40 score: 0
Financial ratios for INDP — annual report dated 2023-12-31
Total revenue: 0
Operating income: -16378474
Net income: -15423471
Capital expenditures: 0
Operating cash flow: -13405315
Depreciation & amortization: 1284
Net tangible assets: 12076498
Owner earnings: -15422187
Return on net tangible assets (%): -127.70413243971888
Buffett classification: The Gruesome
Stock price: 49.28
Shares outstanding: 133242324
Book value: 12076498
P/B ratio: 543.7157135056868
Market cap (USD): 6566181726.72
Debt to equity: 0.014495344594103357
Current ratio: 5.045078427357724
Quick ratio: 5.045078427357724
Free cash flow (dilution-adjusted): -16371253
Buyback yield (%): 0
Retained earnings: -45417156
Capitalized R&D asset: 11859227.190000001
ROCI (R&D-adjusted, %): -55.83537062806546
Rule of 40 score: 0
Financial ratios for INDP — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 34.72
Shares outstanding: 133242324
Market cap (USD): 4626173489.28
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INDP — annual report dated 2024-12-31
Total revenue: 0
Operating income: -15365751
Net income: -15022027
Capital expenditures: 0
Operating cash flow: -12323188
Depreciation & amortization: 735
Net tangible assets: 3944875
Owner earnings: -15021292
Return on net tangible assets (%): -380.77992331822935
Buffett classification: The Gruesome
Stock price: 23.58
Shares outstanding: 133242324
Book value: 3944875
P/B ratio: 796.4394308869101
Market cap (USD): 3141853999.9199996
Debt to equity: 0.021335023289711333
Current ratio: 1.9500772124891828
Quick ratio: 1.9500772124891828
Free cash flow (dilution-adjusted): -14629037
Buyback yield (%): 0
Retained earnings: -60439183
Capitalized R&D asset: 14444777.500000002
ROCI (R&D-adjusted, %): -82.5490004954326
Rule of 40 score: 0
Financial ratios for INDP — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 23.58
Shares outstanding: 133242324
Market cap (USD): 3141853999.9199996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INDP — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -4572559
Net income: -4532430
Capital expenditures: 0
Operating cash flow: -5047127
Depreciation & amortization: 0
Net tangible assets: 2799731
Owner earnings: -4532430
Return on net tangible assets (%): -161.88805281650275
Buffett classification: The Gruesome
Stock price: 15.4
Shares outstanding: 133242324
Book value: 2799731
P/B ratio: 732.9031930567616
Market cap (USD): 2051931789.6000001
Debt to equity: 0.021256327840067493
Current ratio: 1.8993637177049119
Quick ratio: 1.8993637177049119
Free cash flow (dilution-adjusted): -5288018
Buyback yield (%): 0
Retained earnings: -64971613
Capitalized R&D asset: 2810840
ROCI (R&D-adjusted, %): -48.099661632776176
Rule of 40 score: 0
Financial ratios for INDP — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -4456763
Net income: -5228919
Capital expenditures: 0
Operating cash flow: -4018189
Depreciation & amortization: 0
Net tangible assets: -1673356
Owner earnings: -5228919
Buffett classification: The Gruesome
Stock price: 10.53
Shares outstanding: 133242324
Book value: -1673356
Market cap (USD): 1403041671.72
Debt to equity: -3.906446685582745
Current ratio: 0.7533639398615904
Quick ratio: 0.7533639398615904
Free cash flow (dilution-adjusted): -4198952
Buyback yield (%): 0
Retained earnings: -70200532
Capitalized R&D asset: 4050376.8
ROCI (R&D-adjusted, %): -166.13094004057518
Rule of 40 score: 0
Financial ratios for INDP — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -2648487
Net income: -2975117
Capital expenditures: 0
Operating cash flow: -2567427
Depreciation & amortization: 0
Net tangible assets: 4605727
Owner earnings: -2975117
Return on net tangible assets (%): -64.59603445883788
Buffett classification: The Gruesome
Stock price: 2.87
Shares outstanding: 133242324
Book value: 4605727
P/B ratio: 83.02825371108622
Market cap (USD): 382405469.88
Debt to equity: 0.001885912907994764
Current ratio: 2.8818515659091672
Quick ratio: 2.8818515659091672
Free cash flow (dilution-adjusted): -2718041
Buyback yield (%): 0
Retained earnings: -73175649
Capitalized R&D asset: 3897266.58
ROCI (R&D-adjusted, %): -38.762697344841065
Rule of 40 score: 0
Financial ratios for INDP — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -8155704
Net income: -8112450
Capital expenditures: 0
Operating cash flow: -3190513
Depreciation & amortization: 0
Net tangible assets: 3151593
Owner earnings: -8112450
Return on net tangible assets (%): -257.40792037550534
Buffett classification: The Gruesome
Stock price: 2.91
Shares outstanding: 133242324
Book value: 3151593
P/B ratio: 123.02831071144023
Market cap (USD): 387735162.84000003
Debt to equity: 0
Current ratio: 1.5117406218159233
Quick ratio: 1.5117406218159233
Free cash flow (dilution-adjusted): -3976327
Buyback yield (%): 0
Retained earnings: -81288099
Capitalized R&D asset: 4577304.03
ROCI (R&D-adjusted, %): -96.87188617304342
Rule of 40 score: 0
Financial ratios for INDP — annual report dated 2025-12-31
Total revenue: 0
Operating income: -19833513
Net income: -20848916
Capital expenditures: 0
Operating cash flow: -14823256
Depreciation & amortization: 0
Net tangible assets: 3151593
Owner earnings: -20848916
Return on net tangible assets (%): -661.5358011012208
Buffett classification: The Gruesome
Stock price: 2.91
Shares outstanding: 133242324
Book value: 3151593
P/B ratio: 123.02831071144023
Market cap (USD): 387735162.84000003
Debt to equity: 0
Current ratio: 1.5117406218159233
Quick ratio: 1.5117406218159233
Free cash flow (dilution-adjusted): -16181338
Buyback yield (%): 0
Retained earnings: -81288099
Capitalized R&D asset: 16714357.3
ROCI (R&D-adjusted, %): -93.44535777547642
Rule of 40 score: 0
Financial ratios for ITUB — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.43
Shares outstanding: 5404129565
Market cap (USD): 13132034842.95
Buyback yield (%): 0
Retained earnings: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ITUB — annual report dated 2022-12-31
Total revenue: 25828787878.787876
Net income: 5727651515.151515
Capital expenditures: 420833333.3333333
Operating cash flow: 24551704545.454544
Depreciation & amortization: 1089015151.5151515
Net tangible assets: 27386931818.181816
Owner earnings: 6395833333.333333
Return on net tangible assets (%): 23.353595706866386
Buffett classification: The Gruesome
Stock price: 3.17
P/E ratio: 2.9909450104868727
Shares outstanding: 5404129565
Book value: 33542992424.24243
P/B ratio: 0.5107204063483881
Market cap (USD): 17131090721.05
Debt to equity: 2.4164036429954767
Effective tax rate (%): 17.583256118166457
COGS to revenue (%): 0
SG&A to revenue (%): 37.13996597641815
Free cash flow (dilution-adjusted): 22898484848.484848
Buyback yield (%): 0
Receivables turnover: 1.7401112642270198
Capitalized R&D asset: 0
FCF margin (%): 88.65489528949377
Rule of 40 score: 88.65489528949377
Financial ratios for ITUB — annual report dated 2023-12-31
Total revenue: 30593814432.989693
Net income: 6984948453.608248
Capital expenditures: 746804123.7113403
Operating cash flow: 15977938144.329899
Depreciation & amortization: 1346185567.0103095
Net tangible assets: 34394432989.69073
Owner earnings: 7584329896.907217
Return on net tangible assets (%): 22.05103918759329
Buffett classification: The Gruesome
Stock price: 4.91
P/E ratio: 3.7987790948468723
Shares outstanding: 5404129565
Book value: 41041237113.40204
P/B ratio: 0.6465272011862727
Market cap (USD): 26534276164.15
Debt to equity: 2.2699522732981676
Effective tax rate (%): 14.667506297229219
COGS to revenue (%): 0
SG&A to revenue (%): 34.48241002830571
Free cash flow (dilution-adjusted): 14109072164.948456
Buyback yield (%): 0.5353899793280978
Receivables turnover: 1.537393538761216
Capitalized R&D asset: 0
FCF margin (%): 46.11740126701712
Revenue growth (%): 18.448510152948902
Rule of 40 score: 64.56591141996603
Financial ratios for ITUB — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.01
Shares outstanding: 5404129565
Market cap (USD): 27074689120.649998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ITUB — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.78
Shares outstanding: 5404129565
Market cap (USD): 20427609755.7
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ITUB — annual report dated 2024-12-31
Total revenue: 25658252427.184467
Net income: 6816828478.964401
Capital expenditures: 203559870.5501618
Operating cash flow: 1143851132.6860843
Depreciation & amortization: 1161326860.841424
Net tangible assets: 30273948220.064728
Owner earnings: 7774595469.255664
Return on net tangible assets (%): 25.680811147397282
Buffett classification: The Gruesome
Stock price: 3.78
P/E ratio: 2.996644234006504
Shares outstanding: 5404129565
Book value: 35806472491.909424
P/B ratio: 0.5705004803339865
Market cap (USD): 20427609755.7
Debt to equity: 2.3356410766255107
Effective tax rate (%): 11.413912019513834
COGS to revenue (%): 0
SG&A to revenue (%): 37.22125523434741
Free cash flow (dilution-adjusted): 53236245.954692565
Buyback yield (%): 1.4060226914155782
Receivables turnover: 1.5817887995530995
Capitalized R&D asset: 0
FCF margin (%): 0.2074819635739872
Revenue growth (%): -16.13254867782406
Rule of 40 score: -15.925066714250075
Financial ratios for ITUB — quarterly report dated 2025-03-31
Total revenue: 7394444444.444445
Net income: 1858854166.6666667
Capital expenditures: 46527777.777777776
Operating cash flow: -2033680555.5555556
Depreciation & amortization: 319097222.2222222
Net tangible assets: 30744097222.222225
Owner earnings: 2131423611.1111112
Return on net tangible assets (%): 6.932789717990129
Buffett classification: The Gruesome
Stock price: 4.84
P/E ratio: 3.517756740097506
Shares outstanding: 5404129565
Book value: 36635763888.888916
P/B ratio: 0.7139468191226311
Market cap (USD): 26155987094.6
Debt to equity: 2.4412336154524157
Effective tax rate (%): 16.903376018626307
COGS to revenue (%): 0
SG&A to revenue (%): 31.49652516904583
Free cash flow (dilution-adjusted): -2224479166.6666665
Buyback yield (%): 0.05509148697048089
Receivables turnover: 0.43263009273837216
Capitalized R&D asset: 0
FCF margin (%): -30.083114199849735
Rule of 40 score: -30.083114199849735
Financial ratios for ITUB — quarterly report dated 2025-06-30
Total revenue: 7001459854.014598
Net income: 2079927007.29927
Capital expenditures: 41605839.41605839
Operating cash flow: 2536131386.861314
Depreciation & amortization: 329197080.2919708
Net tangible assets: 33648357664.233574
Owner earnings: 2367518248.1751823
Return on net tangible assets (%): 7.03605885255948
Buffett classification: The Gruesome
Stock price: 6.03
P/E ratio: 8.273346458630103
Shares outstanding: 5404129565
Book value: 39863321167.88318
P/B ratio: 0.8174657886559739
Market cap (USD): 32586901276.95
Debt to equity: 2.4062879089589906
Effective tax rate (%): -18.016152412507765
COGS to revenue (%): 0
SG&A to revenue (%): 44.195683903252714
Free cash flow (dilution-adjusted): 2144343065.6934304
Buyback yield (%): 0
Receivables turnover: 0.3642889017593498
Capitalized R&D asset: 0
FCF margin (%): 30.627085070892413
Revenue growth (%): -5.314592507691391
Rule of 40 score: 25.312492563201022
Financial ratios for ITUB — quarterly report dated 2025-09-30
Total revenue: 7925939849.62406
Net income: 2180451127.8195486
Capital expenditures: 46240601.5037594
Operating cash flow: 14230075187.969925
Depreciation & amortization: 421428571.4285714
Net tangible assets: 35919924812.030075
Owner earnings: 2555639097.7443604
Return on net tangible assets (%): 7.114823071368017
Buffett classification: The Gruesome
Stock price: 6.6
P/E ratio: 5.82871402325957
Shares outstanding: 5404129565
Book value: 42238157894.73682
P/B ratio: 0.8444320705909478
Market cap (USD): 35667255129
Debt to equity: 2.3423435852020646
Effective tax rate (%): 15.445732196224213
COGS to revenue (%): 0
SG&A to revenue (%): 37.30493762747237
Free cash flow (dilution-adjusted): 13861842105.263157
Buyback yield (%): 1.0071157004277738
Receivables turnover: 0.37832648446892886
Capitalized R&D asset: 0
FCF margin (%): 174.89209315562303
Revenue growth (%): 13.204103356807368
Rule of 40 score: 188.0961965124304
Financial ratios for ITUB — annual report dated 2025-12-31
Total revenue: 30153832116.78832
Net income: 8366605839.416058
Capital expenditures: 214598540.1459854
Operating cash flow: 6289416058.39416
Depreciation & amortization: 1353832116.788321
Net tangible assets: 32920072992.700726
Owner earnings: 9505839416.058393
Return on net tangible assets (%): 28.87551135796721
Buffett classification: The Gruesome
Stock price: 7.01
P/E ratio: 4.527875338907327
Shares outstanding: 5404129565
Book value: 39247445255.47443
P/B ratio: 0.9652334821810064
Market cap (USD): 37882948250.65
Debt to equity: 2.620915397347916
Effective tax rate (%): 8.758208955223882
COGS to revenue (%): 0
SG&A to revenue (%): 35.1391586935604
Free cash flow (dilution-adjusted): 4958576642.335766
Buyback yield (%): 1.4860411619887655
Receivables turnover: 1.269439963125144
Capitalized R&D asset: 0
FCF margin (%): 16.44426692809983
Revenue growth (%): 17.52098940628109
Rule of 40 score: 33.96525633438092
Financial ratios for ITUB — quarterly report dated 2025-12-31
Total revenue: 7685948905.1094885
Net income: 2215875912.408759
Capital expenditures: 79197080.29197079
Operating cash flow: -7923722627.737226
Depreciation & amortization: 338686131.38686126
Net tangible assets: 32920072992.700726
Owner earnings: 2475364963.5036497
Return on net tangible assets (%): 7.519317967650027
Buffett classification: The Gruesome
Stock price: 7.01
P/E ratio: 4.544985773086588
Shares outstanding: 5404129565
Book value: 39247445255.47443
P/B ratio: 0.9652334821810064
Market cap (USD): 37882948250.65
Debt to equity: 2.620915397347916
Effective tax rate (%): 13.182728052616529
COGS to revenue (%): 0
SG&A to revenue (%): 22.082670528739996
Free cash flow (dilution-adjusted): -8304744525.547444
Buyback yield (%): 0.5255335195234176
Receivables turnover: 0.32356917876622876
Capitalized R&D asset: 0
FCF margin (%): -108.05099836178447
Revenue growth (%): -3.0279178124970803
Rule of 40 score: -111.07891617428155
Financial ratios for IVF — annual report dated 2021-12-31
Total revenue: 4160116
Gross profit: 4015064
Operating income: -5216524
Net income: -6654940
Capital expenditures: 415710
Operating cash flow: -6029914
Depreciation & amortization: 166082
Net tangible assets: 7178587
Owner earnings: -6904568
Return on net tangible assets (%): -96.18282818053191
Buffett classification: The Gruesome
Stock price: 3836160
Shares outstanding: 1786035
Book value: 7310680
P/B ratio: 937192.713345407
Market cap (USD): 6851516025600
Debt to equity: 0.2904722953268369
Current ratio: 5.032597661300363
Quick ratio: 4.802931195750372
Interest coverage ratio: -4.1225644263801815
COGS to revenue (%): 3.486729696960373
R&D to revenue (%): 5.202499161081085
SG&A to revenue (%): 216.7044861249061
Free cash flow (dilution-adjusted): -9192752
Buyback yield (%): 0
Retained earnings: -38891022
Inventory turnover: 0.5040500672404986
Receivables turnover: 82.4275014860313
Capitalized R&D asset: 216430
ROCI (R&D-adjusted, %): -53.78941341246398
FCF margin (%): -220.97345362485083
Rule of 40 score: -220.97345362485083
Financial ratios for IVF — annual report dated 2022-12-31
Total revenue: 822196
Gross profit: -28574
Operating income: -10626481
Net income: -10892511
Capital expenditures: 10785
Operating cash flow: -6603319
Depreciation & amortization: 306319
Net tangible assets: -977612
Owner earnings: -10596977
Buffett classification: The Gruesome
Stock price: 488448.01
Shares outstanding: 1786035
Book value: -977612
Market cap (USD): 872385241540.35
Debt to equity: -2.322283278028502
Current ratio: 0.18606532944078874
Quick ratio: 0.10709540578878701
Interest coverage ratio: -178.76156110690553
COGS to revenue (%): 103.47532705097082
R&D to revenue (%): 66.1695021625014
SG&A to revenue (%): 1213.404468034386
Free cash flow (dilution-adjusted): -8840466
Buyback yield (%): 0
Retained earnings: -49783533
Inventory turnover: 3.2274793059233238
Receivables turnover: 10.657247663611972
Capitalized R&D asset: 689051.1
ROCI (R&D-adjusted, %): -974.3053478475913
Rosenberg metric: -18.683352585131452
FCF margin (%): -1075.226101805409
Revenue growth (%): -80.23622418221031
Rule of 40 score: -1155.4623259876191
Financial ratios for IVF — annual report dated 2023-12-31
Total revenue: 3020575
Gross profit: 1086138
Operating income: -6767155
Net income: -8034612
Capital expenditures: 444722
Operating cash flow: -4755054
Depreciation & amortization: 200894
Net tangible assets: -9079821
Owner earnings: -8278440
Buffett classification: The Gruesome
Stock price: 29160
Shares outstanding: 1786035
Book value: 892596
P/B ratio: 58347.539760429136
Market cap (USD): 52080780600
Debt to equity: 7.059957696427051
Current ratio: 0.1574149104792703
Quick ratio: 0.12436349595989951
Interest coverage ratio: -7.308661002323123
COGS to revenue (%): 64.04201186860118
R&D to revenue (%): 5.493821540600714
SG&A to revenue (%): 247.8486380904298
Free cash flow (dilution-adjusted): -6593271
Buyback yield (%): 0
Retained earnings: -57818145
Inventory turnover: 7.313367888184434
Receivables turnover: 21.491106367840626
Capitalized R&D asset: 601875.7100000001
ROCI (R&D-adjusted, %): -62.22494616971542
Rosenberg metric: 2.0489409844442443
FCF margin (%): -218.2786721071319
Revenue growth (%): 267.3789461393634
Rule of 40 score: 49.10027403223148
Financial ratios for IVF — quarterly report dated 2024-09-30
Total revenue: 1433151
Gross profit: 444686
Operating income: -1300402
Net income: -1630662
Capital expenditures: 0
Operating cash flow: -640807
Depreciation & amortization: 230495
Net tangible assets: -9382608
Owner earnings: -1400167
Buffett classification: The Gruesome
Stock price: 5112
Shares outstanding: 1786035
Book value: -23316
Market cap (USD): 9130210920
Debt to equity: -228.8239406416195
Current ratio: 0.2261556811898342
Quick ratio: 0.19824970556150812
Interest coverage ratio: -4.752427557020638
COGS to revenue (%): 68.97144822841416
R&D to revenue (%): 0
SG&A to revenue (%): 105.68272289521481
Free cash flow (dilution-adjusted): -747137
Buyback yield (%): 0
Retained earnings: -63541125
Inventory turnover: 4.092361896008512
Receivables turnover: 5.5753566412890825
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.547551174786417
FCF margin (%): -52.132468944305245
Rule of 40 score: -52.132468944305245
Financial ratios for IVF — annual report dated 2024-12-31
Total revenue: 6532000
Gross profit: 2874234
Operating income: -6116050
Net income: -9258953
Capital expenditures: 108113
Operating cash flow: -2974400
Depreciation & amortization: 919603
Net tangible assets: 3172441
Owner earnings: -8447463
Return on net tangible assets (%): -266.2764413900842
Buffett classification: The Gruesome
Stock price: 5832
Shares outstanding: 1786035
Book value: 12584358
P/B ratio: 827.7065957595929
Market cap (USD): 10416156120
Debt to equity: 0.6960029268080263
Current ratio: 0.07032272752507661
Quick ratio: 0.058023729872902226
Interest coverage ratio: -5.908410721996864
COGS to revenue (%): 55.997642375995106
R&D to revenue (%): 0.0747091243110839
SG&A to revenue (%): 123.481338028169
Free cash flow (dilution-adjusted): -4747749
Buyback yield (%): 0
Retained earnings: -67327733
Inventory turnover: 16.644063631896035
Receivables turnover: 57.75011493439898
Capitalized R&D asset: 295597.34
ROCI (R&D-adjusted, %): -22.27555061903225
Rosenberg metric: 10.775232757841453
FCF margin (%): -72.68446111451317
Revenue growth (%): 116.25021725995879
Rule of 40 score: 43.56575614544562
Financial ratios for IVF — quarterly report dated 2024-12-31
Total revenue: 1685966
Gross profit: 728547
Operating income: -3464144
Net income: -3623493
Capital expenditures: 78874
Operating cash flow: -617379
Depreciation & amortization: 231810
Net tangible assets: 3172441
Owner earnings: -3470557
Return on net tangible assets (%): -109.39705419265479
Buffett classification: The Gruesome
Stock price: 5832
Shares outstanding: 1786035
Book value: 12584358
P/B ratio: 827.7065957595929
Market cap (USD): 10416156120
Debt to equity: 0.6960029268080263
Current ratio: 0.07032272752507661
Quick ratio: 0.058023729872902226
Interest coverage ratio: -14.942991234729796
COGS to revenue (%): 56.78756273851311
R&D to revenue (%): 28.753842011048857
SG&A to revenue (%): 206.17859434887774
Free cash flow (dilution-adjusted): -865620
Buyback yield (%): 0
Retained earnings: -67327733
Inventory turnover: 4.356577965453851
Receivables turnover: 14.90580683948085
Capitalized R&D asset: 484780
ROCI (R&D-adjusted, %): -10.946640149020382
FCF margin (%): -51.34267239078368
Revenue growth (%): 17.640499849632036
Rule of 40 score: -33.70217254115165
Financial ratios for IVF — quarterly report dated 2025-03-31
Total revenue: 1637185
Gross profit: 592256
Operating income: -1199528
Net income: -17403586
Capital expenditures: 14650
Operating cash flow: -3545534
Depreciation & amortization: 234462
Net tangible assets: -23454815
Owner earnings: -17183774
Buffett classification: The Gruesome
Stock price: 1200
Shares outstanding: 1786035
Book value: 3335365
P/B ratio: 642.5809469128566
Market cap (USD): 2143242000
Debt to equity: 2.6496440419564276
Current ratio: 0.08382529900841153
Quick ratio: 0.07226172614870863
Interest coverage ratio: -3.8966082919967904
COGS to revenue (%): 63.82473575069403
R&D to revenue (%): 16.22681615089315
SG&A to revenue (%): 95.12193185253957
Free cash flow (dilution-adjusted): -3630839
Buyback yield (%): 0.18663314735340197
Retained earnings: -84873449
Inventory turnover: 4.8273983867540124
Receivables turnover: 9.430028684322693
Capitalized R&D asset: 590465.6000000001
ROCI (R&D-adjusted, %): -8.695987509130996
Rosenberg metric: -0.2811398985106646
FCF margin (%): -221.77328768587543
Revenue growth (%): -2.8933560937765055
Rule of 40 score: -224.66664377965193
Financial ratios for IVF — quarterly report dated 2025-06-30
Total revenue: 1863654
Gross profit: 770051
Operating income: -1592735
Net income: -5284858
Capital expenditures: 8877
Operating cash flow: -1717621
Depreciation & amortization: 169737
Net tangible assets: -4783358
Owner earnings: -5123998
Buffett classification: The Gruesome
Stock price: 528
Shares outstanding: 1786035
Book value: 2631473
P/B ratio: 358.3644901543736
Market cap (USD): 943026480
Debt to equity: 2.7076553702052046
Current ratio: 0.11227868965710361
Quick ratio: 0.0952196027171489
Interest coverage ratio: -7.196362814865018
COGS to revenue (%): 58.68063492472315
R&D to revenue (%): 0
SG&A to revenue (%): 117.67468639565068
Free cash flow (dilution-adjusted): -2407178
Buyback yield (%): 0
Retained earnings: -90203241
Inventory turnover: 5.143684945745987
Receivables turnover: 7.6929433861014225
Capitalized R&D asset: 337971.61
ROCI (R&D-adjusted, %): -25.616941431369728
Rosenberg metric: 0.6692501402152351
FCF margin (%): -129.16442644396437
Revenue growth (%): 13.832828910599595
Rule of 40 score: -115.33159753336477
Financial ratios for IVF — quarterly report dated 2025-09-30
Total revenue: 1757094
Gross profit: 629345
Operating income: -1635484
Net income: -2644625
Capital expenditures: 8062
Operating cash flow: -1776537
Depreciation & amortization: 136741
Net tangible assets: -1460759
Owner earnings: -2515946
Buffett classification: The Gruesome
Stock price: 152
Shares outstanding: 1786035
Book value: 5848722
P/B ratio: 46.41651971148569
Market cap (USD): 271477320
Debt to equity: 0.7239000246549588
Current ratio: 0.12296846826723284
Quick ratio: 0.10222552694320533
Interest coverage ratio: -11.217080581332345
COGS to revenue (%): 64.18262198835122
R&D to revenue (%): 0
SG&A to revenue (%): 121.11406674884782
Free cash flow (dilution-adjusted): -2277947
Buyback yield (%): 0
Retained earnings: -93092303
Inventory turnover: 5.880982676442674
Receivables turnover: 6.408074398249453
Capitalized R&D asset: 87668.79000000001
ROCI (R&D-adjusted, %): -17.81918652421583
FCF margin (%): -129.64286486664912
Revenue growth (%): -5.717799548628662
Rule of 40 score: -135.36066441527777
Financial ratios for IVF — annual report dated 2025-12-31
Total revenue: 6841250
Gross profit: 2528512
Operating income: -5840003
Net income: -23323054
Capital expenditures: 43412
Operating cash flow: -7014485
Depreciation & amortization: 677364
Net tangible assets: 20090
Owner earnings: -22689102
Return on net tangible assets (%): -112937.29218516676
Buffett classification: The Gruesome
Stock price: 18.83
Shares outstanding: 1786035
Book value: 7224221
P/B ratio: 4.65531703002995
Market cap (USD): 33631039.05
Debt to equity: 0.47056298526858464
Current ratio: 0.26728631080345605
Quick ratio: 0.24548403741559052
Interest coverage ratio: -4.485154453587123
COGS to revenue (%): 63.04020464096474
R&D to revenue (%): 0
SG&A to revenue (%): 112.42318289786223
Free cash flow (dilution-adjusted): -8527108
Buyback yield (%): 11.893774658740435
Retained earnings: -91369403
Inventory turnover: 19.146195611157232
Receivables turnover: 31.488334414971717
Capitalized R&D asset: 58031.450000000004
ROCI (R&D-adjusted, %): -59.28647248172418
Rosenberg metric: -70.84467213114755
FCF margin (%): -124.64254339484744
Revenue growth (%): 4.734384568279241
Rule of 40 score: -119.9081588265682
Financial ratios for IVF — quarterly report dated 2025-12-31
Total revenue: 1583317
Gross profit: 536860
Operating income: -1412256
Net income: 2010015
Capital expenditures: 11823
Operating cash flow: 25207
Depreciation & amortization: 136425
Net tangible assets: 20090
Owner earnings: 2134617
Return on net tangible assets (%): 10625.271279243405
Buffett classification: The Gruesome
Stock price: 18.83
P/E ratio: 4.182933840045969
Shares outstanding: 1786035
Book value: 7224221
P/B ratio: 4.65531703002995
Market cap (USD): 33631039.05
Debt to equity: 0.47056298526858464
Current ratio: 0.26728631080345605
Quick ratio: 0.24548403741559052
Effective tax rate (%): -8.086010010518143
Interest coverage ratio: -2.252017598272703
COGS to revenue (%): 66.09270285103995
R&D to revenue (%): 0
SG&A to revenue (%): 114.48699155001809
Free cash flow (dilution-adjusted): -211144
Buyback yield (%): 0
Retained earnings: -91369403
Inventory turnover: 4.645696172747977
Receivables turnover: 7.287559317509194
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.28180931476428
FCF margin (%): -13.335548093022433
Revenue growth (%): -9.89002295836193
Rule of 40 score: -23.225571051384364
Financial ratios for KNT.TO — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 81102.36220472441
Buffett classification: The Gruesome
Stock price: 5.661417322834646
Shares outstanding: 245120724
Market cap (USD): 1387730713.0393703
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KNT.TO — annual report dated 2022-12-31
Total revenue: 155479411.76470587
Gross profit: 67502205.88235293
Operating income: 48204411.76470588
Net income: 26119852.94117647
Capital expenditures: 52741176.47058823
Operating cash flow: 53770588.23529411
Depreciation & amortization: 14955882.352941176
Net tangible assets: 227430882.35294116
Owner earnings: -11665441.176470585
Return on net tangible assets (%): -5.129224780637943
Capex to operating income (%): 109.41151346898927
Buffett classification: The Gruesome
Stock price: 5.639705882352941
P/E ratio: 52.92559617937675
Shares outstanding: 245120724
Book value: 227430882.35294113
P/B ratio: 6.078368842117516
Market cap (USD): 1382408789.0294118
Debt to equity: 0.03264404828874966
Current ratio: 3.599173553719008
Quick ratio: 3.0071639187673904
Effective tax rate (%): 40.56816850981245
Interest coverage ratio: 20.365952159055606
COGS to revenue (%): 45.581503130734156
SG&A to revenue (%): 4.686642831470027
Free cash flow (dilution-adjusted): -2188970.588235294
Buyback yield (%): 0
Retained earnings: 103568382.35294117
Inventory turnover: 3.3806734479130127
Receivables turnover: 7.227398571282086
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.324469783635145
FCF margin (%): -1.4078845317140534
Rule of 40 score: -1.4078845317140534
Financial ratios for KNT.TO — annual report dated 2023-12-31
Total revenue: 159332575.75757575
Gross profit: 67203787.87878788
Operating income: 42552272.72727273
Net income: 25123484.848484848
Capital expenditures: 77479545.45454545
Operating cash flow: 56386363.63636363
Depreciation & amortization: 24132575.757575758
Net tangible assets: 265827272.72727272
Owner earnings: -28223484.848484844
Return on net tangible assets (%): -10.61722695302258
Capex to operating income (%): 182.08086310954442
Buffett classification: The Gruesome
Stock price: 4.931818181818182
P/E ratio: 48.11796017368754
Shares outstanding: 245120724
Book value: 265827272.7272727
P/B ratio: 4.547655441674363
Market cap (USD): 1208890843.3636363
Debt to equity: 0.013565427538957857
Current ratio: 3.0809416384676447
Quick ratio: 2.328487279107658
Effective tax rate (%): 35.33838984537992
Interest coverage ratio: 16.964361220175174
COGS to revenue (%): 53.03657776995897
SG&A to revenue (%): 5.796433037433613
Free cash flow (dilution-adjusted): -26143181.818181816
Buyback yield (%): 0
Retained earnings: 131830303.03030303
Inventory turnover: 3.0965216667129334
Receivables turnover: 7.552120363388272
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.390538089314386
FCF margin (%): -16.40793271173788
Revenue growth (%): 2.4782470869526145
Rule of 40 score: -13.929685624785268
Financial ratios for KNT.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.829629629629629
Shares outstanding: 245120724
Market cap (USD): 1428963035.4666665
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KNT.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.06993006993007
Shares outstanding: 245120724
Market cap (USD): 1487865653.3706293
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KNT.TO — annual report dated 2024-12-31
Total revenue: 246851748.25174826
Gross profit: 145724475.52447554
Operating income: 123169230.76923077
Net income: 77779020.97902098
Capital expenditures: 111763636.36363637
Operating cash flow: 129432167.83216783
Depreciation & amortization: 23260839.160839163
Net tangible assets: 331986013.986014
Owner earnings: -10723776.223776221
Return on net tangible assets (%): -3.2301891561696916
Capex to operating income (%): 90.73989962073901
Buffett classification: The Gruesome
Stock price: 6.06993006993007
P/E ratio: 19.12939549305905
Shares outstanding: 245120724
Book value: 331986013.986014
P/B ratio: 4.481711851371276
Market cap (USD): 1487865653.3706293
Debt to equity: 0.13891603825251717
Current ratio: 2.267313859755569
Quick ratio: 1.8459954927624167
Effective tax rate (%): 32.49905931761079
Interest coverage ratio: 486.55248618784526
COGS to revenue (%): 40.293995999977334
SG&A to revenue (%): 4.285576688819766
Free cash flow (dilution-adjusted): 13282517.482517485
Buyback yield (%): 0
Retained earnings: 199469230.76923078
Inventory turnover: 3.6577945790258704
Receivables turnover: 14.389287461275071
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 32.862103128329224
FCF margin (%): 5.38076702984153
Revenue growth (%): 54.92861210461619
Rule of 40 score: 60.30937913445772
Financial ratios for KNT.TO — quarterly report dated 2025-03-31
Total revenue: 101119580.41958043
Gross profit: 77247552.44755246
Operating income: 70586713.28671329
Net income: 49118881.11888112
Capital expenditures: 32069230.76923077
Operating cash flow: 44064335.66433567
Depreciation & amortization: 4567832.167832168
Net tangible assets: 385287412.5874126
Owner earnings: 21617482.517482515
Return on net tangible assets (%): 5.610741958142227
Capex to operating income (%): 45.432389859221914
Buffett classification: The Good
Stock price: 8.678321678321678
P/E ratio: 10.82697958727221
Shares outstanding: 245120724
Book value: 385287412.5874126
P/B ratio: 5.521167895440875
Market cap (USD): 2127236492.895105
Debt to equity: 0.11842036006178296
Current ratio: 2.976638368688252
Quick ratio: 2.5574140001263928
Effective tax rate (%): 30.828696636958984
Interest coverage ratio: 700.9652777777778
COGS to revenue (%): 23.607720555182883
SG&A to revenue (%): 3.733030891902546
Free cash flow (dilution-adjusted): 10604195.804195805
Buyback yield (%): 0
Retained earnings: 248588111.8881119
Inventory turnover: 0.8576704688206622
Receivables turnover: 2.5997554880350946
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.121968516010323
FCF margin (%): 10.48678778155061
Rule of 40 score: 10.48678778155061
Financial ratios for KNT.TO — quarterly report dated 2025-06-30
Total revenue: 70615328.46715328
Gross profit: 46706569.34306569
Operating income: 40418248.17518248
Net income: 28613868.613138683
Capital expenditures: 36486131.38686131
Operating cash flow: 33463503.649635036
Depreciation & amortization: 4470072.9927007295
Net tangible assets: 434871532.8467153
Owner earnings: -3402189.7810218967
Return on net tangible assets (%): -0.7823436403736986
Capex to operating income (%): 90.27143192530656
Buffett classification: The Gruesome
Stock price: 11.211678832116787
P/E ratio: 35.35465864848844
Shares outstanding: 245120724
Book value: 434871532.8467153
P/B ratio: 6.319601594967219
Market cap (USD): 2748214832.5839415
Debt to equity: 0.10867208035261693
Current ratio: 3.0599479942989567
Quick ratio: 2.5741734031094623
Effective tax rate (%): 28.365982018858265
Interest coverage ratio: 432.60156249999994
COGS to revenue (%): 33.44428020631984
SG&A to revenue (%): 4.591546675211642
Free cash flow (dilution-adjusted): -4709489.051094891
Buyback yield (%): 0
Retained earnings: 288089051.0948905
Inventory turnover: 0.7246522878451925
Receivables turnover: 2.186529551361736
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.281337863868583
FCF margin (%): -6.66921637741232
Revenue growth (%): -30.166513573191622
Rule of 40 score: -36.83572995060394
Financial ratios for KNT.TO — quarterly report dated 2025-09-30
Total revenue: 127731654.676259
Gross profit: 96214388.48920864
Operating income: 88964028.77697842
Net income: 61633812.94964029
Capital expenditures: 41879136.69064748
Operating cash flow: 43449640.28776979
Depreciation & amortization: 5170503.597122302
Net tangible assets: 495461870.50359714
Owner earnings: 24925179.85611511
Return on net tangible assets (%): 5.030695869851836
Capex to operating income (%): 47.07423580786026
Buffett classification: The Good
Stock price: 12.100719424460433
P/E ratio: 21.282989615090308
Shares outstanding: 245120724
Book value: 495461870.50359714
P/B ratio: 5.986610237493685
Market cap (USD): 2966137106.2446046
Debt to equity: 0.08702003217693831
Current ratio: 3.285195586760281
Quick ratio: 2.7865195586760283
Effective tax rate (%): 30.973943310182577
Interest coverage ratio: 936.8181818181818
COGS to revenue (%): 24.674593206305936
SG&A to revenue (%): 3.025677707874535
Free cash flow (dilution-adjusted): 252517.98561151093
Buyback yield (%): 0
Retained earnings: 345576978.4172662
Inventory turnover: 0.8811496842189951
Receivables turnover: 2.132184460189744
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.228090896206357
FCF margin (%): 0.19769413169470632
Revenue growth (%): 80.88375066565523
Rule of 40 score: 81.08144479734993
Financial ratios for KNT.TO — quarterly report dated 2025-12-31
Total revenue: 129020437.95620437
Gross profit: 94997810.21897809
Operating income: 87713138.68613137
Net income: 54803649.63503649
Capital expenditures: 45148905.109489046
Operating cash flow: 81502189.7810219
Depreciation & amortization: 5964233.576642335
Net tangible assets: 560259124.0875912
Owner earnings: 15618978.10218978
Return on net tangible assets (%): 2.7878132511676688
Capex to operating income (%): 51.47336623199381
Buffett classification: The Good
Stock price: 16.562043795620436
P/E ratio: 20.90794523868941
Shares outstanding: 245120724
Book value: 560259124.0875912
P/B ratio: 7.24611165005765
Market cap (USD): 4059700166.1021895
Debt to equity: 0.07104898020337305
Current ratio: 3.27814644315122
Quick ratio: 2.688395726569964
Effective tax rate (%): 30.279139737018056
Interest coverage ratio: 551.2247706422019
COGS to revenue (%): 26.369952137951323
SG&A to revenue (%): 2.5622602654476747
Free cash flow (dilution-adjusted): 34578832.11678832
Buyback yield (%): 0
Retained earnings: 405426277.3722627
Inventory turnover: 0.6864856107690949
Receivables turnover: 2.60812725019182
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.259980277374634
FCF margin (%): 26.801050023195554
Revenue growth (%): 1.0089772055422335
Rule of 40 score: 27.810027228737788
Financial ratios for KNT.TO — annual report dated 2025-12-31
Total revenue: 434488321.16788316
Gross profit: 319954014.5985401
Operating income: 292072262.7737226
Net income: 197221167.88321167
Capital expenditures: 157599270.07299268
Operating cash flow: 205043795.62043795
Depreciation & amortization: 20448175.18248175
Net tangible assets: 560259124.0875912
Owner earnings: 60070072.992700756
Return on net tangible assets (%): 10.721837523043957
Capex to operating income (%): 53.958999247761405
Buffett classification: The Good
Stock price: 16.562043795620436
P/E ratio: 20.584505252023554
Shares outstanding: 245120724
Book value: 560259124.0875912
P/B ratio: 7.24611165005765
Market cap (USD): 4059700166.1021895
Debt to equity: 0.07104898020337305
Current ratio: 3.27814644315122
Quick ratio: 2.688395726569964
Effective tax rate (%): 30.375369455589308
Interest coverage ratio: 643.3102893890675
COGS to revenue (%): 26.360733071370134
SG&A to revenue (%): 3.316427243052907
Free cash flow (dilution-adjusted): 41973722.627737224
Buyback yield (%): 0
Retained earnings: 405426277.3722627
Inventory turnover: 2.3109959056231406
Receivables turnover: 8.783111019300005
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 47.48370391379005
FCF margin (%): 9.66049501973124
Revenue growth (%): 76.0118468858387
Rule of 40 score: 85.67234190556994
Financial ratios for MANAPPURAM.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.3783463009363048
Shares outstanding: 939336102
Market cap (USD): 1294730441.5276275
Buyback yield (%): 0
Retained earnings: 602912963.207174
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MANAPPURAM.NS — annual report dated 2023-03-31
Total revenue: 543046772.2289891
Net income: 182724969.5493301
Capital expenditures: 130450.66991473813
Operating cash flow: -377982460.41412914
Depreciation & amortization: 24833008.526187576
Net tangible assets: 1166738367.8440926
Owner earnings: 207427527.4056029
Return on net tangible assets (%): 17.778409720843324
Buffett classification: The Gruesome
Stock price: 1.4272838002436055
P/E ratio: 7.3372522905613495
Shares outstanding: 939336102
Book value: 1177250304.506699
P/B ratio: 1.138839545197965
Market cap (USD): 1340699201.368575
Debt to equity: 3.0179618167192177
Effective tax rate (%): 26.499987751402465
COGS to revenue (%): 0
SG&A to revenue (%): 2.3945510668143424
Free cash flow (dilution-adjusted): -399014007.3081608
Buyback yield (%): 1.817002345263088e-05
Retained earnings: 671874908.6479903
Receivables turnover: 20173.81900452489
Capitalized R&D asset: 0
FCF margin (%): -73.47691353920922
Rule of 40 score: -73.47691353920922
Financial ratios for MANAPPURAM.NS — annual report dated 2024-03-31
Total revenue: 712101930.6871327
Net income: 263520086.3412879
Capital expenditures: 105768.07770715913
Operating cash flow: -413688691.689651
Depreciation & amortization: 29553423.671903107
Net tangible assets: 1376302554.263101
Owner earnings: 292967741.9354839
Return on net tangible assets (%): 21.286579831448794
Buffett classification: The Gruesome
Stock price: 2.012835892514395
P/E ratio: 7.1748967886700585
Shares outstanding: 939336102
Book value: 1388293320.5420313
P/B ratio: 1.3619091824931964
Market cap (USD): 1890729421.240163
Debt to equity: 2.9646767921645876
Effective tax rate (%): 25.748221753752386
COGS to revenue (%): 0
SG&A to revenue (%): 2.252241328964346
Free cash flow (dilution-adjusted): -430042211.2963185
Buyback yield (%): 0
Retained earnings: 839378822.4007674
Receivables turnover: 43.68263939973517
Capitalized R&D asset: 0
FCF margin (%): -60.3905414048457
Revenue growth (%): 31.13086516732988
Rule of 40 score: -29.25967623751582
Financial ratios for MANAPPURAM.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 1485852842.8093646
Buffett classification: The Gruesome
Stock price: 2.3561872909698995
Shares outstanding: 939336102
Book value: 1500332059.245103
P/B ratio: 1.4751746267391035
Market cap (USD): 2213251785.481605
Debt to equity: 3.116707720380422
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MANAPPURAM.NS — quarterly report dated 2024-12-31
Total revenue: 188214244.0843921
Net income: 32877957.80393985
Capital expenditures: 0
Depreciation & amortization: 8214244.08439212
Owner earnings: 41092201.88833197
Buffett classification: The Gruesome
Stock price: 2.1658701480359013
P/E ratio: 15.469939118682195
Shares outstanding: 939336102
Market cap (USD): 2034480022.2942064
Effective tax rate (%): 25.95330532361857
COGS to revenue (%): 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MANAPPURAM.NS — annual report dated 2025-03-31
Total revenue: 737610357.727379
Net income: 142172901.56651857
Capital expenditures: 5981646.013560907
Operating cash flow: -54543605.330839366
Depreciation & amortization: 31257189.618891746
Net tangible assets: 1443036824.8772502
Owner earnings: 167448445.1718494
Return on net tangible assets (%): 11.603892727137657
Buffett classification: The Gruesome
Stock price: 2.6913292099428174
P/E ratio: 17.78160719385486
Shares outstanding: 939336102
Book value: 1455326630.8159924
P/B ratio: 1.7371101687660022
Market cap (USD): 2528062689.2664256
Debt to equity: 2.898174564361857
Effective tax rate (%): 27.72306711390458
COGS to revenue (%): 0
SG&A to revenue (%): 1.5344117356647946
Free cash flow (dilution-adjusted): -77435702.59527706
Buyback yield (%): 0
Retained earnings: 878781271.9195697
Receivables turnover: 46.73233146192247
Capitalized R&D asset: 0
FCF margin (%): -10.498185360880916
Revenue growth (%): 3.582131425431223
Rule of 40 score: -6.916053935449693
Financial ratios for MANAPPURAM.NS — quarterly report dated 2025-03-31
Total revenue: 168733925.64881927
Net income: -22348608.83797054
Capital expenditures: 0
Depreciation & amortization: 7707505.260696749
Net tangible assets: 1443036824.8772502
Owner earnings: -14641103.57727379
Return on net tangible assets (%): -1.0146036001901209
Buffett classification: The Gruesome
Stock price: 2.6913292099428174
Shares outstanding: 939336102
Book value: 1455326630.8159924
P/B ratio: 1.7371101687660022
Market cap (USD): 2528062689.2664256
Debt to equity: 2.898174564361857
COGS to revenue (%): 0
Buyback yield (%): 0
Retained earnings: 878781271.9195697
Receivables turnover: 10.690372850222941
Capitalized R&D asset: 0
Revenue growth (%): -10.35007660038641
Rule of 40 score: -10.35007660038641
Financial ratios for MANAPPURAM.NS — quarterly report dated 2025-06-30
Total revenue: 162425696.2321554
Net income: 16192370.69974257
Capital expenditures: 0
Depreciation & amortization: 8751462.672595367
Owner earnings: 24943833.372337937
Buffett classification: The Gruesome
Stock price: 3.1995085420079574
P/E ratio: 112.47082597090004
Shares outstanding: 939336102
Market cap (USD): 3005413882.165458
Effective tax rate (%): -30.486603624901498
COGS to revenue (%): 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -3.7385661433569557
Rule of 40 score: -3.7385661433569557
Financial ratios for MANAPPURAM.NS — quarterly report dated 2025-12-31
Total revenue: 155467305.33585832
Net income: 26853068.95399354
Capital expenditures: 0
Depreciation & amortization: 8604210.760833241
Owner earnings: 35457279.71482678
Buffett classification: The Gruesome
Stock price: 3.425866102261335
P/E ratio: 60.0663071825628
Shares outstanding: 939336102
Market cap (USD): 3218039710.472096
Effective tax rate (%): 21.234934786197787
COGS to revenue (%): 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -4.284045602212752
Rule of 40 score: -4.284045602212752
Financial ratios for MARI.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.968503937007874
Shares outstanding: 134980260
Market cap (USD): 400689433.22834647
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0